ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is NRX Pharmaceuticals, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -16.34
- The company has been able to generate a Return on Equity (avg) of 0.23% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 26
- INTEREST(9M) At USD 1.14 MM has Grown at inf%
- OPERATING CASH FLOW(Y) Lowest at USD -19.78 MM
- DEBT-EQUITY RATIO (HY) Highest at 14,964.71 %
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 15.68%, its profits have risen by 44.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is NRX Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
NRX Pharmaceuticals, Inc.
10.88%
0.05
87.72%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.40%
EBIT Growth (5y)
-270.48%
EBIT to Interest (avg)
-16.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
-0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
44.73%
ROCE (avg)
0
ROE (avg)
0.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-4.54
EV to EBIT
-4.01
EV to EBITDA
-4.05
EV to Capital Employed
-2.77
EV to Sales
53.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(HY)
Higher at USD 2.17 MM
RAW MATERIAL COST(Y)
Fallen by -2,343% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 32.95 times
-26What is not working for the Company
INTEREST(9M)
At USD 1.14 MM has Grown at inf%
OPERATING CASH FLOW(Y)
Lowest at USD -19.78 MM
DEBT-EQUITY RATIO
(HY)
Highest at 14,964.71 %
OPERATING PROFIT(Q)
Lowest at USD -6.33 MM
PRE-TAX PROFIT(Q)
Lowest at USD -6.73 MM
NET PROFIT(Q)
Lowest at USD -6.73 MM
Here's what is working for NRX Pharmaceuticals, Inc.
Net Sales
Higher at USD 2.17 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Debtors Turnover Ratio
Highest at 32.95 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -2,343% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NRX Pharmaceuticals, Inc.
Interest
At USD 1.14 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Pre-Tax Profit
At USD -6.73 MM has Fallen at -80.58%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -6.73 MM has Fallen at -80.58%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -6.33 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (USD MM)
Debt-Equity Ratio
Highest at 14,964.71 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Cash Flow
Lowest at USD -19.78 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
Lowest at USD -6.73 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -6.73 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Footer loading
